Dune Medical Devices Inc. announced interim results from a study using its MarginProbe system in breast-conserving surgery for tumor removal.
The study’s findings established that use of the device during surgery to remove ductal carcinoma contributes to a 50 percent reduction in the necessity for additional procedures to remove residual cancer.